Mefenorex
![]()  | |
| Clinical data | |
|---|---|
| Trade names | Rondimen, Pondinil, Anexate | 
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | 
  | 
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.037.511 | 
| Chemical and physical data | |
| Formula | C12H18ClN | 
| Molar mass | 211.73 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
| (verify) | |
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[2][3] Mefenorex produces amphetamine as a metabolite,[4] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[5]
References
- ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
 - ↑ Vincendeau MJ (1970). "[A new regulator of appetite: mefenorex]". Bordeaux Medical (in French). 3 (7): 1951–3. PMID 5455004.
 - ↑ Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G (February 1980). "[The treatment of obesity with the appetite curbing agent Mefenorex]". Die Medizinische Welt (in German). 31 (8): 306–9. PMID 7374423.
 - ↑ Rendić S, Slavica M, Medić-Sarić M (1994). "Urinary excretion and metabolism of orally administered mefenorex". European Journal of Drug Metabolism and Pharmacokinetics. 19 (2): 107–17. doi:10.1007/BF03188831. PMID 8001591. S2CID 7170057.
 - ↑ Engel J, Kristen G, Schaefer A, von Schlichtegroll A (June 1986). "Mefenorex (Rondimen)". Drug and Alcohol Dependence. 17 (2–3): 229–34. doi:10.1016/0376-8716(86)90010-4. PMID 3743406.
 
| DRAsTooltip Dopamine releasing agents | 
  | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAsTooltip Norepinephrine releasing agents | 
  | ||||||||||||||
| SRAsTooltip Serotonin releasing agents | 
  | ||||||||||||||
| Others | 
 
  | ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins  | |||||||||||||||
| Phenethylamines | 
 
 
 
 
  | 
|---|---|
| Amphetamines | 
  | 
| Phentermines | 
  | 
| Cathinones | 
  | 
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives)  | 
  | 
| Miscellaneous | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
